YPrime Launches eCOA Gen 5


YPrime, LLC has announced the launch of their fifth-generation electronic clinical outcome assessment (eCOA) platform. YPrime’s newest platform features an improved user experience for patients, clinical investigators, sponsors, and CROs. YPrime’s platform aims to help patients remain engaged and compliant through straightforward design. They offer a customized solution with the necessary control and security that collects data from specification to submission.

For more information, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.